Published in Law and Health Weekly, March 22nd, 2008
This document is for consultation only and does not constitute the Institute's final guidance to the National Health Service (NHS). However, if implemented without any revisions, these proposals will significantly limit the prescribing options for pulmonary hypertension. This will be of particular concern to those patients in the more advanced stages of primary pulmonary hypertension (PPH), which is a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.